BMSN. BMSN. Bio-Matrix Scientific Group's Subsidiary,

New Post Public Reply Private Reply Replies (0) Message Board
Stephen218
BMSN. BMSN.
Bio-Matrix Scientific Group's Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product
Date : 09/25/2013 @ 8:30AM
Source : Marketwired
Stock : Bio-matrix Scientific Group, Inc. (QB) (BMSN)
Quote : 0.003 0.0 (0.00%) @ 5:33AM
Bio-Matrix Scientific Group's Subsidiary, Regen BioPharma Announces dCellVax Breast Cancer Immunotherapeutic Product
Print
Alert
Bio-matrix Scientific Group, Inc. (QB) (USOTC:BMSN)
Intraday Stock Chart
Today : Wednesday 25 September 2013



Bio-Matrix Scientific Group Inc. (OTCQB: BMSN) announced today that its Regen BioPharma subsidiary is currently developing research plans for its breast cancer immunotherapeutic product, dCellVax. This cell therapy is based on patent # 8,389,708 obtained from Dr. Wei-Ping Min of the University of Western Ontario as well as an international patent portfolio licensed from Benitech Biopharma Ltd.
The dCellVax therapeutic product is based on extracting blood from patients, growing a specialized type of immune cell from the blood called the "dendritic cell" and then subsequently genetically modifying the dendritic cell to become resistant to cancer's immune suppressive activity. It is known that cancer modifies the immune system by producing proteins which result in immune suppression. One such protein which cancer stimulates is an enzyme, indolamine 2,3 deoxygenase (IDO), which cancer turns on in dendritic cells. While dendritic cells are usually immune stimulators, dendritic cells found in cancer patients suppress the immune system as a result of expressing IDO.

Researchers at the University of Western Ontario, led by Dr. Wei-Ping Min, have demonstrated that using a genetic blockade of IDO in dendritic cells makes them resistant to the effects of cancer, and allows them to stimulate potent immune responses against tumors. The use of these modified dendritic cells has been previously demonstrated and published in peer-reviewed journals in the melanoma and breast cancer mouse models(1),(2).

Regen is currently working with the contract research organization (CRO) bioRASI LLC together with Dr. Wei-Ping Min's group at manufacturing human dCellVax. Additionally, the recruitment of David Suhy, PhD from Benitec's subsidiary Tacera to Regen's Scientific Advisory Board will provide in-house clinical translation experience in the area of genetic based therapies. Dr. Suhy was essential in the development of the gene-based hepatitis drug in collaboration with Pfizer.

Regen identified the following milestones in the anticipated further development of dCellVax:

a) Generation of human dCellVax: 2 months

b) In vitro demonstration of dCellVax efficacy: 1 month

c) FDA-requested toxicology: 4 months

d) IND submission: 1 month

Regen BioPharma's Chairman & CEO David Koos commented "I am excited to see the progress our company is making. Currently in our pipeline we have two products under development, HemaXellerate (a treatment for aplastic anemia) and now dCellVax (a cancer immuno-therapeutic). I believe these two areas represent a solid foundation for our company."

About Regen BioPharma: Regen BioPharma, Inc., a subsidiary of Bio-Matrix Scientific Group, Inc. (OTCQB: BMSN), is a biotechnology company focused on identifying undervalued regenerative medicine applications in the stem cell space and rapidly advancing these technologies through pre-clinical and Phase I/ II clinical trials. For more information refer to the company's website http://www.regenbiopharma.com/

Disclaimer: This news release may contain forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.

(1) Zheng et al. Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model. Int J Cancer. 2013 Feb 15;132(4):967-77).

(2) Zheng et al. J Immunol. 2006 Oct 15;177(8):5639-46

Contact:



Bio-Matrix Scientific Group, Inc. and

Regen BioPharma Inc.

David R. Koos, PhD

Chairman & Chief Executive Officer

619-702-1404

RIVULET MEDIA INC. (RIVU) Stock Research Links

RIVU Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Align Wagner Collection Tests Men's Footwear Depth

Updated Category News Views 18

Three pairs of shoes are not a revolution, but they can expose whether a young brand has its footing. Align, established in 2025 by H.H. Brown, is rolling out the Wagner collection for Fall-Winter 2026 with a waterproof boot, a penny loafer and a lace-up oxford. That is a sensible little arsenal, not some overstuffed catalog dreamed up by a marketing committee that has...

Continue Reading
COFE+ Barista Test Puts Robotic Coffee on the Clock

Updated Category News Views 84

A swan latte taking 18 seconds less is not nothing, even if it is hardly a verdict on the future of coffee. COFE+, the seventh-generation robotic barista from Shanghai Hi-Dolphin Robot Technology, beat an award-winning human barista across five drinks at a live November 14 competition in Yiwu. That is a clean, visible demonstration of what machines are increasingly built...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 13

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 55

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 68

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
AV Access iDock B12 Chases the Growing Two-PC Desk Boom

Updated Category News Views 149

Cable spaghetti has become an oddly durable tax on anyone running a work laptop beside a gaming tower, and AV Access is taking a proper swing at it with the iDock B12. This is not some mystical new category; it is a KVM switch and docking station mashed together for a desk that has to serve two masters. Still, the company has aimed at the parts that usually get sacrificed...

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 26

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
Nevada’s Space Academy Bid Has Assets, Not a Win Yet

Updated Category News Views 29

Desert acreage and a moon-landing backstory make for a handsome pitch, but Nevada is still standing at the starting line. The state has submitted its official response to NASA’s Request for Information for a proposed United States Space Academy, and the new promotional video is meant to show why the Silver State belongs in the conversation. Fair enough. There is real...

Continue Reading
Huawei's Financial AI Push Targets Scale, Not Demos

Updated Category News Views 79

Banking AI has reached the point where a clever chatbot barely moves the needle. Huawei's message at Singapore FinTech Festival 2026 was aimed squarely at that harder, more expensive problem: turning AI from a scattered pilot project into machinery a financial institution can operate, govern, repeat, and improve without handing over its crown jewels. Ownership Is the...

Continue Reading
Payoneer Gets OCC Nod, but the Finish Line Is Ahead

Updated Category News Views 78

Federal bank paperwork is not usually thrilling, yet Payoneer just found a potentially meaningful lever for its cross-border payments machine. The company received preliminary conditional approval from the Office of the Comptroller of the Currency to form PAYO Digital Bank, a national trust bank intended to support stablecoin services. That is a real regulatory milestone...

Continue Reading

Top 5 Most Recently Viewed Articles

DocGo Inc. Faces Legal Scrutiny Amid Allegations of Misconduct

Updated Category News Views 303

Continuation of Investigation into DocGo Inc. Former Louisiana Attorney General Charles C. Foti, Jr., Esq., is continuing the investigation into DocGo Inc. The firm Kahn Swick & Foti, LLC (KSF), where Foti serves as a partner, is actively pursuing key information related to the conduct of the company’s officers and directors. This scrutiny comes in response to serious...

Continue Reading
Comprehensive Metabolic Panel Testing Market Growth Insights

Updated Category News Views 171

Overview of the Comprehensive Metabolic Panel Testing Market The Comprehensive Metabolic Panel (CMP) testing market is witnessing significant growth, driven by an increasing focus on preventive healthcare and early disease detection. This sector is estimated to expand remarkably in the upcoming years, projected to reach USD 24.48 billion by 2032 with a robust compound...

Continue Reading
Celebrating Future Legal Talents with Ándale Scholarship 2025

Updated Category News Views 244

Two Future Legal Leaders Awarded 2025 Ándale Scholarship At a recent ceremony that brought together the finest minds in the legal profession, two bright law students were honored with the esteemed Ándale Scholarship for the year 2025. This award, conferred by Gastelum Attorneys, is a symbol of recognition for outstanding achievement and potential in the field of law....

Continue Reading
Arkstone and Neslab Join Forces to Innovate Healthcare Solutions

Updated Category News Views 330

Arkstone Partners with Neslab to Transform Healthcare in Peru Arkstone Medical Solutions has forged a pioneering partnership with Neslab, a prominent medical technology firm based in Peru. This collaboration aims to broaden access to precision-guided treatments for infectious diseases across the nation. By leveraging cutting-edge antimicrobial stewardship tools and...

Continue Reading
Opportunity for Investors to Explore NeueHealth's Status

Updated Category News Views 155

Investors Encouraged to Join the Investigation of NeueHealth The Schall Law Firm, a leading national shareholder rights litigation firm, is currently investigating claims on behalf of investors in NeueHealth, Inc. (“NeueHealth” or “the Company”) (NYSE: NEUE). The focus of this investigation is to determine whether the directors and management of NeueHealth have...

Continue Reading